We are live on ! Find out more
ELDN icon

Eledon Pharmaceuticals
ELDN

33 hedge funds and large institutions have $46M invested in Eledon Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

67% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 6

3% more funds holding

Funds holding: 32 → 33 (+1)

0.81% less ownership

Funds ownership: 47.42% → 46.61% (-0.81%)

5% less capital invested

Capital invested by funds: $48.2M → $46M (-$2.18M)

Holders
33
Holders Change
+1
Holders Change %
+3.13%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
10
Reduced
6
Closed
1
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$4K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.23M
2
WP
Woodline Partners
California
+$449K
3
CM
CM Management
Florida
+$308K
4
Morgan Stanley
Morgan Stanley
New York
+$218K
5
BlackRock
BlackRock
New York
+$163K

Top Sellers

Rank Fund Capital Flow
1
ZP
Zimmer Partners
New York
-$1.81M
2
UBS Group
UBS Group
Switzerland
-$147K
3
TRCT
Tower Research Capital (TRC)
New York
-$41.3K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$5.14K
5
Renaissance Technologies
Renaissance Technologies
New York
-$2.41K
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$15.7M – – –
AC
2
Armistice Capital
New York
$5.89M +$75K +28,000 +1%
Vanguard Group
3
Vanguard Group
Pennsylvania
$3.9M +$1.23M +461,092 +42%
SSA
4
Schonfeld Strategic Advisors
New York
$3.73M – – –
ZP
5
Zimmer Partners
New York
$3.57M -$1.81M -674,977 -32%
SFM
6
Sphera Funds Management
Israel
$3.23M +$803 +300 +0%
WP
7
Woodline Partners
California
$2.1M +$449K +167,649 +25%
NCM
8
Nantahala Capital Management
Connecticut
$1.49M – – –
Alyeska Investment Group
9
Alyeska Investment Group
Illinois
$1.25M – – –
Ensign Peak Advisors
10
Ensign Peak Advisors
Utah
$1.1M – – –
Geode Capital Management
11
Geode Capital Management
Massachusetts
$942K +$89.9K +33,569 +10%
CM
12
CM Management
Florida
$685K +$308K +115,000 +72%
BlackRock
13
BlackRock
New York
$538K +$163K +60,788 +39%
State Street
14
State Street
Massachusetts
$402K – – –
Renaissance Technologies
15
Renaissance Technologies
New York
$338K -$2.41K -900 -0.7%
Northern Trust
16
Northern Trust
Illinois
$229K – – –
Morgan Stanley
17
Morgan Stanley
New York
$208K +$218K +81,316 +3,773%
JE
18
JMAC Enterprises
Pennsylvania
$145K – – –
ISL
19
Ingalls & Snyder LLC
New York
$129K – – –
Dimensional Fund Advisors
20
Dimensional Fund Advisors
Texas
$85.2K +$10.7K +3,990 +13%
BCM
21
Bridgeway Capital Management
Texas
$83.2K – – –
MIM
22
Marco Investment Management
Georgia
$75.6K – – –
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$49.5K -$5.14K -1,918 -9%
Mercer Global Advisors
24
Mercer Global Advisors
Colorado
$40.8K – – –
Charles Schwab
25
Charles Schwab
California
$37.3K – – –
1
2

ELDN Hedge Fund Activity: Q3 2024 in Review

33 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Eledon Pharmaceuticals (ELDN) for Q3 2024, worth a combined $46M — down 4.5% from $48.2M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new ELDN positions and 1 closed out — a net gain of 1 holder — while 10 added to existing stakes and 6 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.23M. The largest seller was Zimmer Partners, cutting an estimated $1.81M.

  • 33 institutional investors held Eledon Pharmaceuticals (ELDN) as of Q3 2024, up from 32 in Q2 2024.
  • Funds reported $46M of Eledon Pharmaceuticals stock for Q3 2024, down 4.5% quarter-over-quarter.
  • 2 funds opened new Eledon Pharmaceuticals positions in Q3 2024 and 1 closed out, a net change of +1 holder.
  • The largest Eledon Pharmaceuticals buyer in Q3 2024 was Vanguard Group, an estimated $1.23M added.
  • The largest Eledon Pharmaceuticals seller in Q3 2024 was Zimmer Partners, an estimated $1.81M sold.

Based on aggregated 13F filings for Q3 2024.